Login / Signup
Lukas Veltmaat
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 2
Top Topics
Clinical Trial
Adverse Drug
Tyrosine Kinase
Open Label
Top Venues
Blood
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Lukas Veltmaat
,
Jorge E Cortes
Arterio-occlusive events among patients with chronic myeloid leukemia on tyrosine kinase inhibitors.
Blood
143 (10) (2024)
Lukas Veltmaat
,
Jorge E Cortes
Arterio-occlusive events among patients with chronic myeloid leukemia on tyrosine kinase inhibitors.
Blood
143 (10) (2024)